Summary of change in the 1.2013 version of the Guidelines for Mutiple Guideline from the 1.2012 version include:
MYEL-1
Initial diagnostic workup: changed CBC, diferential, platelets to "CBC, diffential, platelet count."
MYEL-D
Page 1 of 2 :Under maintenance therapy, changed lenalidomide from a category 2A to a category 1 recommendation.